Abstract

NANOSTRUCTURED LIPID CARRIERS FOR TRANSDERMAL DELIVERY OF ANTIHYPERTENSIVE DRUGS: A PROMISING APPROACH FOR MANAGING METABOLIC DISORDERS

Ganesh Prajapati*, Priya Chidrewar, Monika Pate, Siddhi Ambilwade

ABSTRACT

Metabolic disorders, such as hypertension, pose a significant public health concern. Antihypertensive drugs are commonly used, but their oral delivery is associated with side effects and low bioavailability. Nanostructured lipid carriers (NLCs) have emerged as a promising transdermal delivery system, offering improved drug solubility, stability, and bioavailability.

Keywords: Antihypertensive drugs are commonly used, but their oral delivery is associated with side effects and low bioavailability.